Epigallocatechin-3-gallate ameliorates experimental autoimmune encephalomyelitis by altering balance among CD4+ T-cell subsets. [electronic resource]
Producer: 20120217Description: 221-34 p. digitalISSN:- 1525-2191
- Animals
- CD4-Positive T-Lymphocytes -- drug effects
- Catechin -- analogs & derivatives
- Cell Proliferation
- Cytokines -- metabolism
- Demyelinating Diseases -- prevention & control
- Dietary Supplements
- Down-Regulation
- Encephalomyelitis, Autoimmune, Experimental -- immunology
- Female
- Mice
- Mice, Inbred C57BL
- Monocytes -- metabolism
- Multiple Sclerosis -- immunology
- Myelin Proteins -- antagonists & inhibitors
- Myelin-Oligodendrocyte Glycoprotein
- Neuritis -- prevention & control
- Neuroprotective Agents -- pharmacology
- Nuclear Receptor Subfamily 1, Group F, Member 3 -- antagonists & inhibitors
- Random Allocation
- T-Box Domain Proteins -- antagonists & inhibitors
- T-Lymphocyte Subsets -- drug effects
- T-bet Transcription Factor
No physical items for this record
Publication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.
There are no comments on this title.
Log in to your account to post a comment.